February 15, 2024. T-CURX participates at the 6th European CAR-T congress in Valencia, Spain

T-CURX leadership team members will attend and present at the 6th European CAR-T congress of EHA/EBMT from February 15-17 in Valencia, Spain. This flagship event of the European Hematology Association (EHA) and the European Blood and Marrow Transplantation (EBMT) Society is co-hosted by T-CURX co-founder and Chief Medical Officer, Prof. Michael Hudecek

The 6th European CAR-T cell congress organized by the European Hematology Association (EHA) and the European Blood and Marrow Transplantation (EBMT) society and will take place from Feb 15-17, 2023 in the Palacio de Congresos / Valencia Congress Centre at Avda. Cortes Valencianas 60, 46015 València, Spain (see: https://ehaweb.org/meetings/cart6/). Michael Hudecek, MD, Chief Medical Officer and co-founder of T-CURX, will co-chair the conference and will give a presentation at the conference about «New Targets in Solid Tumors» in the Physicians Session on Saturday, Feb 17, from 12:15-14:00. Top key opinion leaders in the CAR-T cell field from Europe and the U.S. will attend the 6th European CAR-T cell conference of EHA/EBMT and present CAR-T innovations to more than 1'000 attendees. The meeting program can be downloaded via the following link https://ehaweb.org/meetings/cart6/program/. In addition, team members of T-CURX leaderhsip team, including Ulf Grawunder, PhD, CEO, as well as Jan Van den Brulle, PhD, Head of Preclincial Development, as well as Senior and Translational Scientists of T-CURX, Thomas Nerreter, PhD, and Sabrina Prommersberger, PhD, will attend the meeting and will be available for meetings on site.